Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SCIB.ST
- Price
- 0.41
- Stock movement up
- +0.01 (2.50%)
- Company name
- Scibase AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 90.01M
- Ent value
- 83.48M
- Price/Sales
- 3.35
- Price/Book
- 2.38
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -19.80%
- 1 year return
- 2.50%
- 3 year return
- -54.19%
- 5 year return
- -10.73%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
SCIB.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.35 |
| Price to Book | 2.38 |
| EV to Sales | 3.11 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 219.54M |
| EPS (TTM) | -0.29 |
| FCF per share (TTM) | -0.28 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 26.87M |
| Gross profit (TTM) | 19.43M |
| Operating income (TTM) | -60.25M |
| Net income (TTM) | -64.20M |
| EPS (TTM) | -0.29 |
| EPS (1y forward) | -0.30 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 72.29% |
| Operating margin (TTM) | -224.24% |
| Profit margin (TTM) | -238.95% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 24.71M |
| Net receivables | 0.00 |
| Total current assets | 49.75M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 56.08M |
| Accounts payable | 3.86M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 16.02M |
| Total liabilities | 18.19M |
| Shareholder's equity | 37.89M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -62.19M |
| Capital expenditures (TTM) | 210.00K |
| Free cash flow (TTM) | -62.40M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -169.45% |
| Return on Assets | -114.49% |
| Return on Invested Capital | -169.45% |
| Cash Return on Invested Capital | -164.68% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.38 |
| Daily high | 0.41 |
| Daily low | 0.38 |
| Daily Volume | 282K |
| All-time high | 17.54 |
| 1y analyst estimate | 1.60 |
| Beta | 1.50 |
| EPS (TTM) | -0.29 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 7 May 2025 |
Downside potential
Loading...
Downside potential data
| SCIB.ST | S&P500 | |
| Current price drop from All-time high | -97.66% | -12.89% |
| Highest price drop | -98.57% | -56.47% |
| Date of highest drop | 16 May 2024 | 9 Mar 2009 |
| Avg drop from high | -76.95% | -11.07% |
| Avg time to new high | 2424 days | 12 days |
| Max time to new high | 2423 days | 1805 days |
COMPANY DETAILS
Marketcap
90.01M
Marketcap category
Small-cap
Description
SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.
Employees
28
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that it has on-boarded several US dermatology practices tha...
January 30, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a new review article has been published highlighting t...
January 28, 2025
SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that updated German guidelines for imaging (S1) has been pu...
January 23, 2025
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration with Kilabs srl, an Italian Company with ...
October 30, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will attend a leading US dermatology conference, Fall Clinical, to further ...
October 21, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin disorders announced today that it continues to expand in California with a c...
June 28, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces the election of Jesper Høiland as the new Chairman of the Board.
June 13, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that a new clinical study has been published presenting the...
May 22, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutio...
April 24, 2024
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will participate at the Redeye Medtech event.
April 23, 2024